Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Charles Matsumoto"'
Autor:
Charles Matsumoto
Publikováno v:
Drug Information Journal. 25:201-203
Autor:
Charles Matsumoto, W.S. Marshall
Publikováno v:
Life Sciences. 8:837-842
Autor:
Charles Matsumoto
Publikováno v:
Life Sciences. 5:1963-1969
Publikováno v:
Clinical pharmacology and therapeutics. 46(3)
Nizatidine, a new H2-receptor antagonist for treatment of duodenal ulcer disease, was evaluated in a unique two-phase, placebo-controlled, randomized, double-blind, multicenter clinical trial. Patients received either 150 mg nizatidine twice daily or
Autor:
Gayle Regel, F. Gilbert McMahon, Jerome R. Ryan, Charles Matsumoto, Ramon Vargas, Walter W. Offen
Publikováno v:
Journal of clinical pharmacology. 28(1)
Nizatidine was studied in six high-acid-secretor (basal secretion, greater than or equal to 5 mEq/hr) male volunteers in a randomized, double-blind, nonbalanced, cross-over, placebo and standard drug-controlled study. Doses of 75 mg, 150 mg, and 300
Publikováno v:
Advances in enzyme regulation. 15
A32390A, 1,6-di-O-(2-isocyano-3-methylcrotonyl)- d -mannitol, obtained from fermentation broths of a species of Pyrenochaeta , inhibited DBH in vitro and lowered heart norepinephrine levels in vivo in rats. A32390A had less effect on adrenal catechol
Publikováno v:
European journal of pharmacology. 19(1)
d-Amphetamine, and to a much lesser extent l-amphetamine, increased serum FFA levels in fed but not in fasted rats. This increase was not altered by adrenalectomy, a finding which distinguishes an amphetamine-induced lipolysis. Hypophysectomy, thyroi
Autor:
William A. Griffin, Charles Matsumoto
Publikováno v:
The Journal of pharmacy and pharmacology. 23(9)
Autor:
Walter N. Shaw, Charles Matsumoto
Publikováno v:
Journal of Pharmacy and Pharmacology. 23:387-388